Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study

While current live, oral rotavirus vaccines (LORVs) are reducing severe diarrhea everywhere, their effectiveness is lower in high burden settings. Alternative approaches are in advanced stages of clinical development, including injectable next-generation rotavirus vaccine (iNGRV) candidates, which h...

Descripción completa

Detalles Bibliográficos
Autores principales: Debellut, Frédéric, Pecenka, Clint, Hausdorff, William P., Clark, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Rotavirus – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009916/
https://www.ncbi.nlm.nih.gov/pubmed/35240926
http://dx.doi.org/10.1080/21645515.2022.2040329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009916/
https://www.ncbi.nlm.nih.gov/pubmed/35240926
http://dx.doi.org/10.1080/21645515.2022.2040329

Ejemplares similares